David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 47,365 shares at $1.63 ($78K) on 2018-08-14, disclosed to the SEC on 2018-08-14.
Scheduled sale ($78k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 988 | $2K | 2.1% |
| 2 | $1.65 | 2,140 | $4K | 4.5% |
| 3 | $1.65 | 29,798 | $49K | 63.1% |
| 4 | $1.63 | 366 | $597 | 0.8% |
| 5 | $1.63 | 792 | $1K | 1.7% |
| 6 | $1.63 | 11,032 |
| $18K |
| 23.1% |
| 7 | $1.63 | 64 | $104 | 0.1% |
| 8 | $1.63 | 146 | $238 | 0.3% |
| 9 | $1.63 | 2,039 | $3K | 4.3% |
| Total | $1.64 avg | 47,365 | $78K | 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |